IFNG and neoplasm: In vivo, anti-DEC205/pSAP was taken up efficiently by tumor DC, reduced growth of MCA101-OVA tumor cells, enhanced presentation of OVA peptide and increased the frequency of IFN-γ-producing antigen specific T cells.